Primary and metastatic peritoneal surface malignancies
Peritoneal surface malignancies comprise a heterogeneous group of primary tumours,
including peritoneal mesothelioma, and peritoneal metastases of other tumours, including …
including peritoneal mesothelioma, and peritoneal metastases of other tumours, including …
The contemporary management of peritoneal metastasis: A journey from the cold past of treatment futility to a warm present and a bright future
JM Foster, C Zhang, S Rehman… - CA: A Cancer …, 2023 - Wiley Online Library
Peritoneal metastasis (PM) is often regarded as a less frequent pattern of spread; however,
collectively across all spectra of primary tumors, the consequences of PM impact a large …
collectively across all spectra of primary tumors, the consequences of PM impact a large …
The role of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the treatment of peritoneal carcinomatosis: A systematic review including evidence …
T Kitai - Surgery Today, 2021 - Springer
The prognosis of peritoneal carcinomatosis is poor. However, the emergence of
cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS+ HIPEC) as a …
cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS+ HIPEC) as a …
Peritoneal Carcinomatosis Risk and Long-Term Survival Following Hepatectomy for Spontaneous Hepatocellular Carcinoma Rupture: Results of a Multicenter French …
E Roussel, M Bubenheim, YP Le Treut… - Annals of surgical …, 2020 - Springer
Background Spontaneous rupture of hepatocellular carcinoma (HCC) remains a life-
threatening complication, with a reported mortality rate of between 16 and 30% and an …
threatening complication, with a reported mortality rate of between 16 and 30% and an …
Surgical outcomes of spontaneously ruptured hepatocellular carcinoma
JH Kwon, GW Song, S Hwang, KH Kim, CS Ahn… - Journal of …, 2021 - Elsevier
Background Surgical and oncological outcomes in ruptured hepatocellular carcinoma
(HCC) are not well known. The objective of this study was to review and compare survival …
(HCC) are not well known. The objective of this study was to review and compare survival …
Living donor liver re-transplantation for recurrent hepatoblastoma in the liver graft following complete eradication of peritoneal metastases under indocyanine green …
N Takahashi, Y Yamada, K Hoshino, M Kawaida… - Cancers, 2019 - mdpi.com
The curability of chemotherapy-resistant hepatoblastoma (HB) largely depends on the
achievement of radical surgical resection. Navigation techniques utilizing indocyanine green …
achievement of radical surgical resection. Navigation techniques utilizing indocyanine green …
Nephrotoxicity Associated with Cytoreductive Surgery Combined with Cisplatin-Based Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Malignant Disease …
C Grillo-Marín, C Antón-Rodríguez, L Prieto… - Journal of Clinical …, 2024 - mdpi.com
Background: Cisplatin is employed in hyperthermic intraperitoneal chemotherapy (HIPEC)
after cytoreductive surgery (CRS) for peritoneal surface malignancies (PSMs). The main …
after cytoreductive surgery (CRS) for peritoneal surface malignancies (PSMs). The main …
New metastasectomy criteria for peritoneal metastasis of hepatocellular carcinoma: a study of the Japanese Society of Hepato‐Biliary‐Pancreatic Surgery
H Iida, M Tani, T Aihara, K Hasegawa… - Journal of Hepato …, 2020 - Wiley Online Library
Abstract Background/Purpose Peritoneal metastasis of hepatocellular carcinoma (HCC) is
rare. We investigated patients who underwent peritoneal metastasectomy in a multicenter …
rare. We investigated patients who underwent peritoneal metastasectomy in a multicenter …
Is cytoreductive surgery and hyperthermic intraperitoneal chemotherapy indicated in hepatobiliary malignancies?
N Leigh, D Solomon, E Pletcher, DM Labow… - World Journal of …, 2020 - Springer
Background Hepatopancreaticobiliary malignancies with peritoneal carcinomatosis exhibit
poor survival with current therapies: hepatocellular carcinoma 11 months with sorafenib, and …
poor survival with current therapies: hepatocellular carcinoma 11 months with sorafenib, and …
[HTML][HTML] The role of hyperthermic intraperitoneal chemotherapy in the treatment of spontaneously ruptured hepatocellular carcinoma: a pilot study
S Ruan, N Shi, Z Chen, H Han, H Wang… - Annals of …, 2020 - ncbi.nlm.nih.gov
Background Spontaneous tumor rupture is a distinctive disease pattern in patients with
hepatocellular carcinoma (HCC). The application of hyperthermic intraperitoneal …
hepatocellular carcinoma (HCC). The application of hyperthermic intraperitoneal …